User menu

Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North America.

Bibliographic reference Wofsy, David ; Diamond, Betty ; Houssiau, Frédéric. Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North America.. In: Arthritis & Rheumatology, Vol. 67, no. 5, p. 1144-1146 (2015)
Permanent URL http://hdl.handle.net/2078.1/169058
  1. Austin Howard A., Klippel John H., Balow James E., Le Riche Nicole G.H., Steinberg Alfred D., Plotz Paul H., Decker John L., Therapy of Lupus Nephritis, 10.1056/nejm198603063141004
  2. Appel G. B., Contreras G., Dooley M. A., Ginzler E. M., Isenberg D., Jayne D., Li L.-S., Mysler E., Sanchez-Guerrero J., Solomons N., Wofsy D., , Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis, 10.1681/asn.2008101028
  3. Rovin Brad H., Furie Richard, Latinis Kevin, Looney R. John, Fervenza Fernando C., Sanchez-Guerrero Jorge, Maciuca Romeo, Zhang David, Garg Jay P., Brunetta Paul, Appel Gerald, , Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study, 10.1002/art.34359
  4. Houssiau Frédéric A., Vasconcelos Carlos, D'Cruz David, Sebastiani Gian Domenico, Garrido Enrique de Ramon, Danieli Maria Giovanna, Abramovicz Daniel, Blockmans Daniel, Mathieu Alessandro, Direskeneli Haner, Galeazzi Mauro, Gül Ahmet, Levy Yair, Petera Peter, Popovic Rajko, Petrovic Radmila, Sinico Renato Alberto, Cattaneo Roberto, Font Josep, Depresseux Geneviève, Cosyns Jean-Pierre, Cervera Ricard, Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide : Immunosuppressive Therapy in Lupus Nephritis, 10.1002/art.10461
  5. Houssiau F A, Vasconcelos C, D'Cruz D, Sebastiani G D, de Ramon Garrido E, Danieli M G, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico R A, Cattaneo R, Font J, Depresseux G, Cosyns J-P, Cervera R, The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide, 10.1136/ard.2008.102533
  6. , Treatment of Lupus Nephritis With Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study : Abatacept in Lupus Nephritis, 10.1002/art.38790
  7. Kawabata Daisuke, Venkatesh Jeganathan, Ramanujam Meera, Davidson Anne, Grimaldi Christine M., Diamond Betty, Enhanced Selection of High Affinity DNA-Reactive B Cells Following Cyclophosphamide Treatment in Mice, 10.1371/journal.pone.0008418
  8. Cambridge G, Isenberg D A, Edwards J C W, Leandro M J, Migone T-S, Teodorescu M, Stohl W, B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response, 10.1136/ard.2007.079418
  9. Thien Marilyn, Phan Tri Giang, Gardam Sandra, Amesbury Michelle, Basten Antony, Mackay Fabienne, Brink Robert, Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches, 10.1016/j.immuni.2004.05.010
  10. Tsuiji Makoto, Yurasov Sergey, Velinzon Klara, Thomas Saskia, Nussenzweig Michel C., Wardemann Hedda, A checkpoint for autoreactivity in human IgM+memory B cell development, 10.1084/jem.20052033